advertisement
Calkins DJ 28
Showing records 1 to 25 | Display all abstracts from Calkins DJ108363 Retinal ganglion cells adapt to ionic stress in experimental glaucoma
Boal AM
Frontiers in neuroscience 2023; 17: 1142668
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
Boal AM
Translational vision science & technology 2023; 12: 1
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Naguib S
Antioxidants (Basel, Switzerland) 2023; 12:
108296 The importance of unambiguous cell origin determination in neuronal repopulation studies
Johnson TV
iScience 2023; 26: 106361
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
McGrady NR
Translational vision science & technology 2023; 12: 1
108363 Retinal ganglion cells adapt to ionic stress in experimental glaucoma
McGrady NR
Frontiers in neuroscience 2023; 17: 1142668
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
DeJulius CR
Antioxidants (Basel, Switzerland) 2023; 12:
108296 The importance of unambiguous cell origin determination in neuronal repopulation studies
Calkins DJ; Fortune B
iScience 2023; 26: 106361
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Backstrom JR
Antioxidants (Basel, Switzerland) 2023; 12:
108363 Retinal ganglion cells adapt to ionic stress in experimental glaucoma
Holden JM
Frontiers in neuroscience 2023; 17: 1142668
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
Chamling X
Translational vision science & technology 2023; 12: 1
108363 Retinal ganglion cells adapt to ionic stress in experimental glaucoma
Risner ML
Frontiers in neuroscience 2023; 17: 1142668
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
Kagitapalli BS
Translational vision science & technology 2023; 12: 1
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Haider AA
Antioxidants (Basel, Switzerland) 2023; 12:
108296 The importance of unambiguous cell origin determination in neuronal repopulation studies
Goldberg JL; La Torre A
iScience 2023; 26: 106361
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
Zack DJ
Translational vision science & technology 2023; 12: 1
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Ang JM
Antioxidants (Basel, Switzerland) 2023; 12:
108363 Retinal ganglion cells adapt to ionic stress in experimental glaucoma
Calkins DJ
Frontiers in neuroscience 2023; 17: 1142668
108296 The importance of unambiguous cell origin determination in neuronal repopulation studies
Lamba DA
iScience 2023; 26: 106361
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Boal AM
Antioxidants (Basel, Switzerland) 2023; 12:
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
Calkins DJ
Translational vision science & technology 2023; 12: 1
108296 The importance of unambiguous cell origin determination in neuronal repopulation studies
Meyer JS
iScience 2023; 26: 106361
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Calkins DJ
Antioxidants (Basel, Switzerland) 2023; 12:
108300 Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
Risner ML
Translational vision science & technology 2023; 12: 1
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway
Duvall CL
Antioxidants (Basel, Switzerland) 2023; 12:
